Start Date: 2026-05-20 00:00:00
End Date: 2026-05-22 00:00:00
Main topic of the event: "Liver and Obesity"
Registration https://www.majovky.sk
Submit your abstract for active participation here: https://majovky.sk/abstrakty/
Start Date: 2026-05-20 00:00:00
End Date: 2026-05-22 00:00:00
Main topic of the event: "Liver and Obesity"
Registration https://www.majovky.sk
Submit your abstract for active participation here: https://majovky.sk/abstrakty/
Date from: 2025-05-21 00:00:00
Date to: 2025-05-23 00:00:00
Save the date. May Hepatology Days 2025 will take place from May 21 to May 23, 2025, at the Grand Hotel Praha in Tatranská Lomnica.
We invite you to participate actively; the congress traditionally features an extensive section dedicated to original scientific research.
More information at https://majovky.sk/
Date from: 2024-05-22 00:00:00
Date to: 2024-05-24 00:00:00
We invite you to the 51st May Hepatology Days, which will take place at Hotel Patria at Štrbské Pleso from 22 to 24 May 2024.
The congress is the most important event in the field of Hepatology in Slovakia and has much to offer not only hepatologists but also gastroenterologists, internists, general practitioners, surgeons, and other specialties. It will also include a nursing section (23 May 2024) and practical workshops dedicated to ultrasound and elastography in hepatology.
We invite you to participate actively; the deadline for abstract submission is 31 March 2024.
Preliminary programme:
22.5.2024
9.00 – 11.30 Pre-congress activities
9.00 – 10.00 Young hepatologists
10.15 – 11.30 Research group
Introduction
Adamcová Selčanová S., Havaj D.: SIRIUS
Žilinčanová D., Šulejová K.: HEGITO registry
Miscellaneous
Discussion
9.00 -11.30 Teaching area – abdominal ultrasonography and elastography
12.00 – 13.00 Lunch
13.00 – 13.15 Opening
13.20 – 14.20 Block 1. Map of steatotic liver disease in Slovakia, present and future (Koller T., Rác M., Pršo M.)
13.21 – 13.31 Koller T., Adamcová Selčanová S., Skladaný Ľ. (Bratislava, Banská Bystrica): Epidemiological map of steatotic liver disease in Slovakia
13.32 – 13.42 Havaj D., Jursová X., Szantová M., Skladaný Ľ., Koller T. (Banská Bystrica, Bratislava): Screening for advanced liver fibrosis in steatosis, comparison of methods in real-world practice.
13.43 – 13.58 Kužela L. (Bratislava): Lifestyle change in the management of steatotic liver disease
13.59 – 14.14 Rác M. (Nitra): Pharmacological treatment of steatotic liver disease—will it be for everyone?
14.15 – 14.20 Discussion
14.25 – 14.45 State of the art 1. (Dražilová S., Jarčuška P., Skladaný Ľ.)
Šperl J. (Prague, Czech Republic): TBA
14.45 – 15.45 Block 2. Liver cirrhosis and its complications (Skladaný Ľ., Jarčuška P., Havaj D.)
14.46 – 14.54 Hrnčár M. (Banská Bystrica): Liver injury (DILI) caused by new drugs for hepatocellular carcinoma
14.55 – 15.03 Šafčák D. (Košice): What have we learned about liver tumours in Slovakia from registries?
15.04 – 15.12 Strachan J., Molčan P. (Banská Bystrica): Endoscopic hepatology and cirrhosis
15.13 – 15.21 Vrbová P., Koller T. (Bratislava): Calprotectin in liver cirrhosis?
15.22 – 15.30 Gazda J., Janičko M., Dražilová S., Jarčuška P. (Košice): Speech analysis and hepatic encephalopathy
15.30 – 15.45 Discussion
15.45 – 16.05 Break
16.05 – 16.50 Symposium supported by Gilead
16.55 – 17.15 State of the art 2. (Jarčuška P., Oltman M.)
Skladaný Ľ. (Banská Bystrica): 10 years of the cirrhosis registry
17.15 – 18.15 Block 3. Working Group Block: Young Hepatologists (Nosáková L., Žilinčanová D., Važanová D.)
17.16 – 17.28 Havaj D. (Banská Bystrica): Cirrhosis-associated immune dysfunction
17.29 – 17.41 Šmíd V. (Prague): MASLD and associated extrahepatic diseases—wolf in sheep’s clothing?
17.42 – 17.54 Schnierer M. (Martin): Portal hypertension from a gastroenterologist’s perspective
17.55 – 18.07 Kováčová K. (Šaľa): Cooperation between the hepatologist and the general practitioner in managing a patient with hepatopathy
18.07 – 18.15 Discussion
18.15 – 18.25 Break
18.25 – 18.55 Symposium supported by Roche
19.00 -19.30 Plenary meeting
20.00 Dinner + ceremonial presentation of SHS awards
23.5.2024
8.30 -11.00 Teaching area: Abdominal ultrasonography and elastography
11.00 – 12.00 Poster session (Gregušová A., Žilinčanová D.)
12.00 – 13.00 Lunch
13.00 – 14.00 Block 4. Alcohol-related liver disease (Szántová M., Janičko M., Vrbová P.)
13.01 – 13.13 Szántová M. (Bratislava): ALD screening in the context of the new MASLD (MetAld) definition
13.14 – 13.26 Gazda J. (Košice): Pitfalls of non-invasive diagnosis of severe alcoholic hepatitis.
13.27 – 13.39 Šulejová K., Skladaný Ľ. (Banská Bystrica): What is new in the treatment of severe alcohol-associated hepatitis?
13.40 – 13.52 Chvála Ľ. (Banská Bystrica): Psychological assessment of liver transplant candidates
13.52 – 14.00 Discussion
14.05 – 15.05 Block 5. Block of the Czech Hepatology Society
15.10 – 16.10 Symposium supported by PRO.MED.CS Praha a.s.
16.10 – 16.30 Break
16.30 -17.25
Block 6. Steatotic liver disease through the eyes of a (non-)hepatologist (Dražilová S., Makara P., Schroner Z., Staníková D.)
16.31 – 16.43 Staníková D., Kosnáčová J., Čierna I., Vitariušová E., Staník J. (Bratislava): Steatotic liver disease in children with early-onset obesity
16.44 – 16.56 Schroner Z. (Košice): Steatotic liver disease through the eyes of a diabetologist
16.57 – 17.09 Keher I., Škuta R., Dobrovodský A. (Trnava): Metabolic-bariatric surgery—a path to long-term weight loss and improvement of associated diseases
17.10 – 17.25 Panel discussion
17.30 – 18.30 Symposium supported by Novo Nordisk
18.30 – 18.45 Break
18.45 – 19.15 Symposium supported by Abbvie
19.15 – 19.30 Lecture supported by Sanofi
20.00 Dinner + award for the best papers
24.5.2023
9.00 – 10.00 Block 7. Viral hepatitis (Kristian P., Oltman M., Šulejová K.)
9.01 – 9.11 Žilinčanová D., Skladaný Ľ. (Banská Bystrica): Neutrophil-to-lymphocyte ratio in patients with viral aetiology of ACLD compared with other causes: analysis of data from the RH7 registry
9.12 – 9.22 Kristian P., Hockicková I., Jurek J., Lami F., Rovňáková A. (Košice): Options for using quantitative HBsAg determination in clinical practice
9.23 – 9.33 Oltman M. (Bratislava): HCC after elimination of chronic hepatitis C
9.34 – 9.44 Hockicková I., Lami F., Hockicko J., Jurek J., Kristian P. (Košice): First experience with routine diagnostics of hepatitis D
9.45 – 9.55 Sekula J., Paraličová Z. (Košice): Hepatitis E at the Clinic of Infectious Diseases and Travel Medicine in Košice
9.55 – 10.00 Discussion
10.05 – 10.35 Symposium supported by Wörwag Pharma
10.35- 11.00 Break
11.00 -12.00 Block 8. Various (Žigrai M., Paraličová Z., Martinková D.)
12.05 – 13.05 Block 9. Autoimmune liver diseases (Dražilová S., Adamcová Selčanová S., Koky T.)
12.06 – 12.18 Adamcová Selčanová S. (Banská Bystrica): Autoimmune hepatitis: treatment management
12.19 – 12.31 Jarčuška P. (Košice): Autoimmune liver diseases: fertility, pregnancy
12.32 – 12.44 Dražilová S., Jarčuška P., Janičko M., Toporcerová D. (Košice): Our experience with obeticholic acid treatment in patients with PBC (lecture supported by MagnaPharm)
12.45 – 12.57 Brunčák M. (Banská Bystrica): Primary sclerosing cholangitis: management of strictures from a gastroenterologist’s perspective
12.57 – 13.05 Discussion
13.05 Closing
13.10 Lunch
More at:
Dátum od: 2026-06-26 00:00:00
Dátum do: 2026-06-27 00:00:00